Literature DB >> 35309880

Safety and Efficacy of Restoring Facial Symmetry Using Polydioxanone Thread Face Lift Technique in Patients with Facial Palsy.

Anuj Bhatnagar1,2,3,4, Roma Rai1,2,3,4, Sanjay Kumar1,2,3,4, Barnali Mitra1,2,3,4, Ajay Chopra1,2,3,4, Gautam Kumar Singh1,2,3,4, Debdeep Mitra1,2,3,4, Chetan Patil1,2,3,4, Sunmeet Sandhu1,2,3,4.   

Abstract

Background: Facial nerve palsy often leads to functional and physiological impairment in patients and they often suffer from social stigma. The use of polydiaxone (PDO) threads has long been used to treat facial furrows and age-related sagging in the face. The basic principle of the thread lift procedure is placing cogged threads in the subcutaneous plane along a planned trajectory. The efficacy and ease of this procedure compared to a traditional face lift has made PDO threads a popular option in the past three decades.
Methods: We treated 50 patients with a drooping face on one side following facial paralysis with thread lifting and botulinum injections to control contralateral hypertrophy and ipsilateral synkinesis. The Facial Grading System or the serial Sunnybrook Facial Grading System (SB scores) was used to assess at all the visits and serial photographs were recorded.
Results: Following the threading procedure, all 50 patients displayed improved facial symmetry. There was significant improvement in the baseline SB scores compared to the scores over following year, with all the scores having significant p value less than 0.05.
Conclusion: Based on our results, subdermal suspension with re-absorbable threads in conjunction with botulinum toxin constitutes an efficient and safe procedure for face lifting and rejuvenation of a drooping face as a result of long-lasting facial paralysis.
Copyright © 2022. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Facial nerve palsy; botulinum toxin; polydiaxone thread

Year:  2022        PMID: 35309880      PMCID: PMC8884188     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  10 in total

1.  Barbed polypropylene sutures for midface elevation: early results.

Authors:  Samson Lee; Nicannor Isse
Journal:  Arch Facial Plast Surg       Date:  2005 Jan-Feb

2.  Elevating the midface with barbed polypropylene sutures.

Authors:  Nicanor G Isse; Peter B Fodor
Journal:  Aesthet Surg J       Date:  2005 May-Jun       Impact factor: 4.283

3.  Barbed sutures in facial rejuvenation.

Authors:  Woffles T L Wu
Journal:  Aesthet Surg J       Date:  2004 Nov-Dec       Impact factor: 4.283

Review 4.  Complications in facelift surgery: avoidance and management.

Authors:  Richard A K Chaffoo
Journal:  Facial Plast Surg Clin North Am       Date:  2013-11       Impact factor: 1.918

5.  Removal of facial soft tissue ptosis with special threads.

Authors:  M A Sulamanidze; P F Fournier; T G Paikidze; G M Sulamanidze
Journal:  Dermatol Surg       Date:  2002-05       Impact factor: 3.398

6.  Psychological and social factors in reconstructive surgery for hemi-facial palsy.

Authors:  E T Bradbury; W Simons; R Sanders
Journal:  J Plast Reconstr Aesthet Surg       Date:  2006       Impact factor: 2.740

7.  Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis.

Authors:  Ki Hoon Choi; Seung Hwan Rho; Jun Myung Lee; Ju Hyun Jeon; Si Young Park; Jin Kim
Journal:  J Plast Reconstr Aesthet Surg       Date:  2013-05-15       Impact factor: 2.740

8.  Thread-lift for facial rejuvenation: assessment of long-term results.

Authors:  Rima F Abraham; Robert J DeFatta; Edwin F Williams
Journal:  Arch Facial Plast Surg       Date:  2009 May-Jun

Review 9.  Botulinum toxin treatment for facial palsy: A systematic review.

Authors:  Lilli Cooper; Michael Lui; Charles Nduka
Journal:  J Plast Reconstr Aesthet Surg       Date:  2017-02-16       Impact factor: 2.740

10.  The emerging technique of the antiptosis subdermal suspension thread.

Authors:  Barry Lycka; Carl Bazan; Eduardo Poletti; Ben Treen
Journal:  Dermatol Surg       Date:  2004-01       Impact factor: 3.398

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.